贝纳利祖马布在严重喘中的有效性和安全性:亚洲的一项随机试验
Kefang Lai1, Dejun Sun2, Ranran Dai3
1Guangzhou Institute of Respiratory Health, State Key Laboratory of Respiratory Disease, National Clinical Research Center for Respiratory Disease, National Center for Respiratory Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, China.
Respiratory medicine
|April 3, 2024
概括
在亚洲,本拉利祖马布显著降低了喘恶化,并改善了亚洲严重酸性喘患者的肺功能. 这项研究证实了benralizumab的存在.
科学领域:
- 肺部病理学 肺部病理学
- 临床试验 临床试验
- 药理学 药理学是指药理学的学科.
背景情况:
- 贝纳利祖马布是治疗严重的酸性喘的补充疗法.
- 此前,大量亚洲人群的临床试验数据缺乏.
研究的目的:
- 评估本拉利祖马布在亚洲严重喘患者的疗效和安全性.
- 评估本拉利祖马布对恶化和肺功能的影响.
主要方法:
- 在中国,韩国和菲律宾进行的3期随机对照试验 (MIRACLE研究).
- 患有严重喘的12-75岁患者接受了本拉利祖马布或安慰剂.
- 主要终点是每年喘恶化率 (AAER);次要终点包括1秒前支气管扩展器强迫呼吸量 (BD前FEV1) 和喘症状总得分 (TASS).
主要成果:
- 在患有血中乙氨基酸细胞计数 (bEOS) ≥300/μL的患者中,本拉利祖马布显著降低了AAER,与安慰剂相比降低了74%.
- 在这个小组中,本拉利祖马布还显著改善了BD前FEV1和TASS.
- 在bEOS<300/μL的患者中,观察到AAER,BD前FEV1和TASS的数值改善. 两组之间不良事件的发生率相似.
结论:
- 奇迹研究表明,本拉利祖马布在亚洲患者中有效性和安全性,患有严重酸性喘.
- 结果与全球第三阶段的研究结果一致,支持在这个人群中使用它.
相关概念视频
Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
288
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
288
Antiasthma Drugs: β2-Adrenoceptor Agonists
261
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
261
Antiasthma Drugs: Leukotriene Modifiers
291
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
291
Asthma: Pathogenesis and Management
394
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
394
Adrenergic Antagonists: Pharmacological Actions of β-Receptor Blockers
797
β-receptor blockers significantly impact the cardiovascular system by counteracting catecholamine-induced sympathetic responses. These medications decrease heart rate, contractility, and cardiac output, potentially leading to cardiac depression, life-threatening bradycardia, and death. Therapeutically, β-blockers function as mild antihypertensives and are utilized in treating angina pectoris and cardiac arrhythmias. However, nonselective β-blockers inhibit β2-receptors in...
797
Asthma-IV: Diagnostic and Management
2.5K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
2.5K


